Interestingly, BRI2 accumulates in the hippocampus in the early stages of Alzheimer’s disease (AD) preventing the BRI2:APP complex formation and therefore resulting in increased APP processing and consequently more Abeta1-40 and Abeta1-42 is produced9. Here, ITM2B is linked to early-onset autosomal dominant Alzheimer disease.